1.National Institutes of Health Stroke Scale: comparison of original and modified versions for Singapore culture.
Shu Han LIM ; Tai Yan GUEK ; Fung Peng WOON ; Deirdre Danyi TAY ; Shu Swen HO ; Szu Chyi NG ; Deidre Anne DE SILVA
Singapore medical journal 2023;64(9):563-566
INTRODUCTION:
The National Institutes of Health Stroke Scale (NIHSS), originally designed in the United States of America, contains items on dysphasia and dysarthria that are deemed culturally unsuitable for the Singapore context. We compared the error rates of dysphasia objects, dysphasia phrases and dysarthria words between the original and alternative items in a cohort of Singaporean subjects without dysphasia or dysarthria.
METHODS:
In this prospective study, 140 English-speaking Singaporean subjects without impairments of dysphasia or dysarthria had an assessment of NIHSS items 9 and 10 using the original and alternative items. Paired analyses were conducted for comparison of error rates.
RESULTS:
The error rates were high for four original dysphasia objects (Hammock: 62.9%, Cactus: 38.6%, Feather: 23.6%, Glove: 20.7%) and significantly lower for alternative items (Snail: 5%, Horse: 1.4%, Hanger: 1.4%, Car: 0%) (P < 0.001). For dysphasia phrases and dysarthria words, the error rates were low and there were no differences in error rates between the original and alternative items.
CONCLUSION
There are cultural issues with several dysphasia objects in the original NIHSS as evidenced by the high error rates, which were lowered with more culturally suitable alternatives. This study formed a basis to derive a more suitable version of the NIHSS for English-speaking subjects in Singapore.
Humans
;
United States
;
Animals
;
Horses
;
Stroke/diagnosis*
;
Singapore
;
Dysarthria/diagnosis*
;
Prospective Studies
;
National Institutes of Health (U.S.)
;
Aphasia/diagnosis*
;
Severity of Illness Index
2.Factors Associated to Returning Home in the First Year after Stroke
Seung Han KIM ; Yong Il SHIN ; Seung Chan KIM ; Sung Hwa KO ; Deog Young KIM ; Jongmin LEE ; Min Kyun SOHN ; Sam Gyu LEE ; Gyung Jae OH ; Yang Soo LEE ; Min Cheol JOO ; Eun Young HAN ; Junhee HAN ; Won Hyuk CHANG ; Ji Hong MIN ; Yun Hee KIM
Brain & Neurorehabilitation 2020;13(1):1-
The objective of this study was to investigate factors affecting the return home one year after a stroke. The subjects of this study consisted of patients who participated in a large-scale multi-objective cohort study of initial stage stroke patients who were admitted to 9 representative hospitals in Korea. We analyzed the distribution of the subjects who had experienced stroke a year earlier by distinguishing the group who returned home and the other group that was hospitalized in rehabilitation hospitals. Based on this distribution, we evaluated the demographic, environmental, clinical, and psychological factors that can affect the return home. Overall, there were 464 subjects in the ‘Return home’ group and 99 subjects in the ‘Rehabilitation hospitalization’ group. job status, inconvenient housing structures, residential types, diagnosis, Functional Ambulation Categories, modified Rankin Scale, Korea-Modified Barthel Index, Function Independence Measure, Fugl-Meyer Assessment, Korean version of Mini-Mental State Examination, Korean version of Frenchay Aphasia Screening Test, Psychosocial Well-being Index-Short Form, Geriatric Depression Scale-Short Form, EuroQol-five Dimensional showed a significant difference between the 2 groups one year after the stroke. The factors affecting the return home one year after a stroke include functional status, activities of daily living, cognition, depression, stress, quality of life, job status. It is expected that factors affecting the rehabilitation of patients with stroke can be considered as basic data for establishing rehabilitation goals and treatment plans.
Activities of Daily Living
;
Aphasia
;
Cognition
;
Cohort Studies
;
Depression
;
Diagnosis
;
Housing
;
Humans
;
Korea
;
Mass Screening
;
Patient Discharge
;
Psychology
;
Quality of Life
;
Rehabilitation
;
Stroke
;
Walking
3.Standard Recipes for the Preparation of Thickened Barium Liquids Used in the Diagnosis of Dysphagia
Jaechun PARK ; Whachun YOO ; Byoungseung YOO
Clinical Nutrition Research 2019;8(4):265-271
Barium sulfate is commonly used to prepare contrast media for videofluorograpy. The flow characteristics of thickened liquids formulated for oropharyngeal imaging are known to be greatly affected by the addition of barium. In this study, thickened barium liquids were prepared by mixing a commercial xanthan gum (XG)-based thickener (Visco-up®) at different concentrations (0.1%–3.0%) with barium powder (Baritop HD®), and differences in the viscosity between thickened non-barium and thickened barium liquids were investigated. In addition, the thickness levels of thickened barium liquids, which are based on the National Dysphagia Diet (NDD) and International Dysphagia Diet Standardization Initiative (IDDSI) guidelines, were classified by measuring the viscosity (NDD) and gravity flow through a syringe (IDDSI) with 0.1%–3.0% thickener concentrations. The apparent viscosity (η(a),₅₀) values of thickened barium liquids were much higher than those of thickened non-barium liquids, indicating that the addition of barium to the XG-based thickener resulted in further thickening. Standard recipes for preparing thickened barium liquids with desirable thickness levels were also established, showing the different thickener concentrations corresponding to the different NDD and IDDSI levels.
Aphasia
;
Barium Sulfate
;
Barium
;
Contrast Media
;
Deglutition Disorders
;
Diagnosis
;
Diet
;
Gingiva
;
Gravitation
;
Syringes
;
Viscosity
4.¹⁸F-THK5351 PET Imaging in Nonfluent-Agrammatic Variant Primary Progressive Aphasia.
Cindy W YOON ; Hye Jin JEONG ; Seongho SEO ; Sang Yoon LEE ; Mee Kyung SUH ; Jae Hyeok HEO ; Yeong Bae LEE ; Kee Hyung PARK ; Nobuyuki OKAMURA ; Kyoung Min LEE ; Young NOH
Dementia and Neurocognitive Disorders 2018;17(3):110-119
BACKGROUND AND PURPOSE: To analyze 18F-THK5351 positron emission tomography (PET) scans of patients with clinically diagnosed nonfluent/agrammatic variant primary progressive aphasia (navPPA). METHODS: Thirty-one participants, including those with Alzheimer's disease (AD, n=13), navPPA (n=3), and those with normal control (NC, n=15) who completed 3 Tesla magnetic resonance imaging, 18F-THK5351 PET scans, and detailed neuropsychological tests, were included. Voxel-based and region of interest (ROI)-based analyses were performed to evaluate retention of 18F-THK5351 in navPPA patients. RESULTS: In ROI-based analysis, patients with navPPA had higher levels of THK retention in the Broca's area, bilateral inferior frontal lobes, bilateral precentral gyri, and bilateral basal ganglia. Patients with navPPA showed higher levels of THK retention in bilateral frontal lobes (mainly left side) compared than NC in voxel-wise analysis. CONCLUSIONS: In our study, THK retention in navPPA patients was mainly distributed at the frontal region which was well correlated with functional-radiological distribution of navPPA. Our results suggest that tau PET imaging could be a supportive tool for diagnosis of navPPA in combination with a clinical history.
Alzheimer Disease
;
Aphasia, Primary Progressive*
;
Basal Ganglia
;
Broca Area
;
Diagnosis
;
Frontal Lobe
;
Humans
;
Magnetic Resonance Imaging
;
Neurofibrillary Tangles
;
Neuropsychological Tests
;
Positron-Emission Tomography
;
Primary Progressive Nonfluent Aphasia
;
tau Proteins
5.The Brain Donation Program in South Korea.
Yeshin KIM ; Yeon Lim SUH ; Seung Joo KIM ; Moon Hwan BAE ; Jae Bum KIM ; Yuna KIM ; Kyung Chan CHOI ; Gi Yeong HUH ; Eun Joo KIM ; Jung Seok LEE ; Hyun Wook KANG ; Sung Mi SHIM ; Hyun Joung LIM ; Young Ho KOH ; Byeong Chae KIM ; Kyung Hwa LEE ; Min Cheol LEE ; Ho Won LEE ; Tae Sung LIM ; William W. SEELEY ; Hee Jin KIM ; Duk L. NA ; Kyung Hoon LEE ; Sang Won SEO
Yonsei Medical Journal 2018;59(10):1197-1204
PURPOSE: Obtaining brain tissue is critical to definite diagnosis and to furthering understanding of neurodegenerative diseases. The present authors have maintained the National Neuropathology Reference and Diagnostic Laboratories for Dementia in South Korea since 2016. We have built a nationwide brain bank network and are collecting brain tissues from patients with neurodegenerative diseases. We are aiming to facilitate analyses of clinic-pathological and image-pathological correlations of neurodegenerative disease and to broaden understanding thereof. MATERIALS AND METHODS: We recruited participants through two routes: from memory clinics and the community. As a baseline evaluation, clinical interviews, a neurological examination, laboratory tests, neuropsychological tests, and MRI were undertaken. Some patients also underwent amyloid PET. RESULTS: We recruited 105 participants, 70 from clinics and 35 from the community. Among them, 11 died and were autopsied. The clinical diagnoses of the autopsied patients included four with Alzheimer's disease (AD), two with subcortical vascular dementia, two with non-fluent variant primary progressive aphasia, one with leukoencephalopathy, one with frontotemporal dementia (FTD), and one with Creutzfeldt-Jakob disease (CJD). Five patients underwent amyloid PET: two with AD, one with mixed dementia, one with FTD, and one with CJD. CONCLUSION: The clinical and neuropathological information to be obtained from this cohort in the future will provide a deeper understanding of the neuropathological mechanisms of cognitive impairment in Asia, especially Korea.
Alzheimer Disease
;
Amyloid
;
Aphasia, Primary Progressive
;
Asia
;
Brain*
;
Cognition Disorders
;
Cohort Studies
;
Creutzfeldt-Jakob Syndrome
;
Dementia
;
Dementia, Vascular
;
Diagnosis
;
Frontotemporal Dementia
;
Humans
;
Korea*
;
Leukoencephalopathies
;
Magnetic Resonance Imaging
;
Memory
;
Neurodegenerative Diseases
;
Neurologic Examination
;
Neuropathology
;
Neuropsychological Tests
6.Role of Positron Emission Tomography as a Biologic Marker in the Diagnosis of Primary Progressive Aphasia: Two Case Reports
Young Jin JEONG ; Kyung Won PARK ; Do Young KANG
Nuclear Medicine and Molecular Imaging 2018;52(5):384-388
Primary progressive aphasia (PPA) is a heterogenous neurodegenerative disorder characterized by declining language and speech ability. Various underlying neuropathologies can induce PPA, and the disorder is divided into three subtypes—progressive non-fluent aphasia, semantic variant aphasia, and logopenic aphasia—according to clinical features. Accurate disease classification and prediction of underlying diseases are necessary for appropriate treatment, but proper use of imaging tests is important because clinical information alone often makes it difficult to make accurate decisions. Because there is a characteristic metabolic pattern according to the subtypes, F-18 fluorodeoxyglucose positron emission tomography (PET) can indicate subtype classification. In addition, PETstudies for imaging amyloid or dopamine transporters play an important role in demonstrating underlying disease. The present case showed that PET imaging studies are useful in diagnosis and could be used as a biomarker in PPA.
Amyloid
;
Aphasia
;
Aphasia, Primary Progressive
;
Biomarkers
;
Classification
;
Diagnosis
;
Dopamine
;
Dopamine Plasma Membrane Transport Proteins
;
Electrons
;
Neurodegenerative Diseases
;
Neuropathology
;
Positron-Emission Tomography
7.An Autopsy Confirmed Case of Semantic Variant Primary Progressive Aphasia with Frontotemporal Lobar Degeneration-TDP type C
Na Yeon JUNG ; Myung Jun LEE ; Jae Hyeok LEE ; Jin Hong SHIN ; Young Min LEE ; Myung Jun SHIN ; Kyoungjune PAK ; Chungsu HWANG ; Jae Woo AHN ; Suk SUNG ; Kyung Un CHOI ; Gi Yeong HUH ; Eun Joo KIM
Journal of the Korean Neurological Association 2018;36(1):35-39
A 62-year-old man presented with a one-year history of word finding difficulty, impaired single word comprehension and personality changes including aggression, apathy and eating change. Brain MRIs showed severe atrophy in the left anterior temporal lobe. The clinical syndromic diagnosis was semantic variant primary progressive aphasia. He died at age 70 of pneumonia. At autopsy, transactive response DNA-binding protein (TDP) immunoreactive long dystrophic neurites were predominantly found in the cerebral cortices, which were compatible with frontotemporal lobar degeneration-TDP type C pathology.
Aggression
;
Apathy
;
Aphasia, Primary Progressive
;
Atrophy
;
Autopsy
;
Brain
;
Cerebral Cortex
;
Comprehension
;
Diagnosis
;
Eating
;
Frontotemporal Dementia
;
Frontotemporal Lobar Degeneration
;
Humans
;
Magnetic Resonance Imaging
;
Middle Aged
;
Neurites
;
Pathology
;
Pneumonia
;
Semantics
;
TDP-43 Proteinopathies
;
Temporal Lobe
8.Frontotemporal Dementia.
Byoung Sun JUN ; Joon Hyuk PARK
Journal of the Korean Society of Biological Psychiatry 2016;23(3):69-79
Frontotemporal dementia (FTD) is a degenerative disease characterized by the selective frontal and temporal lobe atrophy, and progressive deficits in behavior, executive function, or language. The prevalence and incidence of FTD are 15-22/100000 and 2.7-4.1/100000, respectively, in midlife. Hereditary is an important risk factor for FTD. Although there is some controversy regarding the further syndromatic subdivision of the different types of FTD, FTD is clinically classified into behavioral variant of frontotemporal dementia, semantic dementia and progressive nonfluent aphasia. FTD can be misdiagnosed as many psychiatric disorders because of similarity of the prominent behavioral features. Advances in clinical, imaging, and molecular characterization have increased the accuracy of FTD diagnosis, thus developing for the accurate differentiation of these syndromes from psychiatric disorders. We also discuss about therapeutic strategies for symptom management of FTD. Medications such as serotonin reuptake inhibitors, antipsychotics, and other novel treatments have been used in FTD with various rates of success. Further advanced research should be directed at understanding and developing new diagnostic and therapeutic modalities to improve the FTD patients' prognosis and quality of life.
Antipsychotic Agents
;
Atrophy
;
Diagnosis
;
Drug Therapy
;
Executive Function
;
Frontotemporal Dementia*
;
Genetics
;
Incidence
;
Prevalence
;
Primary Progressive Nonfluent Aphasia
;
Prognosis
;
Quality of Life
;
Risk Factors
;
Serotonin Uptake Inhibitors
;
Temporal Lobe
9.Relapsed Brucellosis Presenting as Neurobrucellosis with Cerebral Vasculitis in a Patient Previously Diagnosed with Brucellar Spondylitis: A Case Report.
Eun Jung KIM ; Su Jin LEE ; Eun Young AHN ; Dae Gon RYU ; Yu Hee CHOI ; Tae Hyun KIM
Infection and Chemotherapy 2015;47(4):268-271
Brucellosis is a multisystem disease with various clinical symptoms. Neurobrucellosis is a rare but serious manifestation of brucellosis. A 60-year-old man with a previous diagnosis of brucellar spondylitis presented with sudden onset of aphasia and numbness of the right upper extremity. Cerebral angiography showed diffuse narrowing and dilatation on the distal branches of both the anterior cerebral artery (ACA) and the left middle cerebral artery (MCA) which indicated cerebral vasculitis, and the patient's Brucella agglutinin titer was 1:1280. After combined antimicrobial and steroid therapy was started, the patient's condition improved significantly, and he was discharged after 1 month. Antimicrobial therapy was continued for 16 months on an outpatient basis, and the last Brucella agglutinin titer was 1:40. To our knowledge, this is the first case of relapsed neurobrucellosis with vasculitis in Korea to have been treated successfully.
Anterior Cerebral Artery
;
Aphasia
;
Brucella
;
Brucellosis*
;
Cerebral Angiography
;
Diagnosis
;
Dilatation
;
Humans
;
Hypesthesia
;
Korea
;
Middle Aged
;
Middle Cerebral Artery
;
Outpatients
;
Spondylitis*
;
Upper Extremity
;
Vasculitis
;
Vasculitis, Central Nervous System*
10.Logopenic Progressive Aphasia Revealing Positive Cerebrospinal Fluid Biomarkers for Alzheimer's Disease.
Hyung Jun KIM ; Tae Eun KIM ; Saeromi KIM ; Won Seok CHAE ; Sun Ah PARK
Journal of the Korean Neurological Association 2014;32(2):98-102
Primary progressive aphasia (PPA) is classified into agrammatic, semantic, and logopenic variants, but differential diagnosis is often challenging. There is accumulating evidence that the neuropathology of logopenic PPA is distinct from that of the other types. We report herein a woman with logopenic PPA who was diagnosed by clinical, neuropsychological, and radiologic data during 2 years of follow-up. Interestingly, her cerebrospinal fluid biomarkers were found to be similar to those found in Alzheimer's disease, with a decreased concentration of Abeta42 and an increased concentration of pTau181 (tTau).
Alzheimer Disease*
;
Aphasia*
;
Aphasia, Primary Progressive
;
Biomarkers*
;
Cerebrospinal Fluid*
;
Diagnosis, Differential
;
Female
;
Follow-Up Studies
;
Humans
;
Semantics

Result Analysis
Print
Save
E-mail